Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 31

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT00010283Phase 1/2Completed
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Studychair
NCT00926575Phase 3Terminated
Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)
Acute Gastrointestinal Graft vs Host Disease
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Keith Sullivan, MD

Duke University

Related
4 trials

Shared therapeutic areas:

Acute Gastrointestinal Graft vs Host Disease

Worked with same sponsors:

Soligenix
Collaborated on 1 trial
Similarity Score14%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesChronic Myeloproliferative Disorders+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaGraft vs Host Disease+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerOvary CancerCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Breast CancerCancer of KidneyOvary Cancer
Similarity Score7%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemiaNeuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Breast CancerLymphomaOvary Cancer
Similarity Score7%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

LymphomaOvary Cancer
Similarity Score5%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00010283Phase 1/2StudyChair

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Completed
NCT00926575Phase 3PrincipalInvestigator

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

Acute Gastrointestinal Graft vs Host Disease
Terminated

All 2 trials loaded